Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments | Market Insights | Asia Pacific | 2021

Although the Asia Pacific open surgery instrument market will be severely impacted by the COVID-19 pandemic in the short term, once conditions improve, the instrument market will return to moderate growth through 2029. China and India will be major centers of growth due to their improving health care infrastructure and promising economic and demographic landscapes. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for open surgery instruments in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow strongly through the forecast period, driven by various factors such as rising procedure volumes, product launches, and increasing…
Report
Large-Joint Reconstructive Implants – Market Insights – Asia Pacific
The Asia Pacific large-joint reconstructive implant market is experiencing moderate growth driven by an increasing number of elective procedures, a rising elderly population affected by arthritis…
Report
Gynecological Devices – Market Insights – Asia Pacific
Driven by the rising prevalence of gynecological diseases and aging population in this region, the Asia Pacific gynecological device market will continue to witness modest growth through 2034…
Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Asia Pacific
The GI endoscopy device market will continue to grow moderately throughout the forecast period, supported by the high incidence of gastric cancer and CRC cases in the region. Growth will be…